Viewing Study NCT00126620


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-05-14 @ 11:54 AM
Study NCT ID: NCT00126620
Status: COMPLETED
Last Update Posted: 2015-07-23
First Post: 2005-08-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unspecified adult solid tumor, protocol specific View